Research Manager at the Lab for Translational Genetics

Leuven VIB-KU Leuven Center for Cancer Biology

15 Oct 2021


VIB-KU Leuven Center for Cancer Biology

Diether Lambrechts Lab

Senior Scientific (Managerial)


31 Oct 2021

About the lab

The Laboratory for Translational Genetics, headed by Diether Lambrechts, aspires to tackle important questions in oncology by translating genome-scale data sets into clinically applicable knowledge. Investigations are based on the application of cutting-edge sequencing technologies and advanced bioinformatics, and the integration of genomic data sets with clinical and fundamental biological information. To achieve their goals, the lab relies on the collection of tumor and liquid biopsies within clinical trials and the application of advanced high-throughput and single-cell sequencing technologies.


As a research manager, you will closely collaborate with the head of the lab and regularly report the progress of various projects. You are willing to support and contribute to several research projects of the lab, have a collaborative spirit, and are eager to liaise with clinicians, pathologists, computational biologists, but also technology transfer experts, and industrial collaborators. You need to be able to organise and troubleshoot your work independently, document it thoroughly, and communicate results and experiences with the team in a transparent and professional manner. You have an inspiring work attitude that motivates other scientists of the team to be successful in the projects.

Profile and skills

We are looking for a highly motivated, well-organized, and dynamic candidate with a high level of independence and creative thinking.

  • You hold a Ph.D. in Life Sciences, Engineering, Biology, or equivalent preferably with (basic) knowledge in (preclinical) cancer biology.
  • You have a strong interest in translational research in a multidisciplinary field, including computational biology.
  • You must have good, open communication skills and are willing to support the other scientists of the team.
  • You are fluent in Dutch and English, both oral and written is mandatory. Scientific writing skills in English are very important.
  • The interactions with many different partners require very good interpersonal skills.
  • Experience in communication aspects in science and biomedical research, in particular, the use of social media (Twitter, Facebook, Linkedin) is a plus.
  • You have an interest in the legal aspects of translational research dealing with patient material (ethics, GDPR, etc.)

We offer

  • A dynamic and challenging research work environment where quality, professionalism, and team spirit are encouraged.
  • A broad professional network (academic, clinical, and industrial) in a national and international setting.
  • The ability to learn, work with, and become an expert in translational cancer research.
  • The possibility to be at the start of scientifically cutting-edge and society relevant projects based on multidisciplinary and international collaborations.
  • The opportunity to be part of an international, young, and dynamic team and provide a meaningful contribution to cancer research.
  • An open-ended contract.

How to apply?

Please complete the online application procedure and include:

  • A detailed CV, including a list of your scientific publications
  • An elaborate cover letter describing your motivation

Applications sent by email will not be considered. Application deadline: 31/10/2021

For more information, please contact Diether Lambrechts ( or Ingrid Arijs ( 

VIB is an entrepreneurial and vibrant non-profit research institute in Flanders-Belgium with a clear focus on groundbreaking research in life sciences. The VIB-KULeuven Center for Cancer Biology (CCB), is one of the research departments of VIB located at the University Hospital Campus in Leuven, Belgium. CCB hosts 11 research groups and represents about 200 international researchers, administrative and technical collaborators. The focus of the CCB is to unravel the molecular basis of cancer, and whenever suitable, exploit these insights to develop novel therapeutic or diagnostic strategies.